Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two F508del alleles.
Stahl M, Dohna M, Graeber SY, Sommerburg O, Renz DM, Pallenberg ST, Voskrebenzev A, Schütz K, Hansen G, Doellinger F, Steinke E, Thee S, Röhmel J, Barth S, Rückes-Nilges C, Berges J, Hämmerling S, Wielpütz MO, Naehrlich L, Vogel-Claussen J, Tümmler B, Mall MA, Dittrich AM.
Stahl M, et al. Among authors: graeber sy.
Eur Respir J. 2024 Sep 5;64(3):2400004. doi: 10.1183/13993003.00004-2024. Print 2024 Sep.
Eur Respir J. 2024.
PMID: 38901883
Free PMC article.